161 related articles for article (PubMed ID: 10084816)
1. The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.
Beelen DW; Elmaagacli AH; Schaefer UW
Blood; 1999 Mar; 93(5):1779-10. PubMed ID: 10084816
[No Abstract] [Full Text] [Related]
2. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.
Beelen DW; Graeven U; Elmaagacli AH; Niederle N; Kloke O; Opalka B; Schaefer UW
Blood; 1995 May; 85(10):2981-90. PubMed ID: 7742558
[TBL] [Abstract][Full Text] [Related]
3. Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Morton AJ; Gooley T; Hansen JA; Appelbaum FR; Bruemmer B; Bjerke JW; Clift R; Martin PJ; Petersdorf EW; Sanders JE; Storb R; Sullivan KM; Woolfrey A; Anasetti C
Blood; 1998 Jul; 92(2):394-401. PubMed ID: 9657736
[TBL] [Abstract][Full Text] [Related]
4. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
5. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
Xu L; Guo N; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
[TBL] [Abstract][Full Text] [Related]
6. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
Tomás JF; López-Lorenzo JL; Requena MJ; Aguilar R; Steegmann JL; Cámara R; Alegre A; Arranz R; Figuera A; Fernández-Rañada JM
Bone Marrow Transplant; 1998 Jul; 22(1):47-51. PubMed ID: 9678795
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
Giralt S; Szydlo R; Goldman JM; Veum-Stone J; Biggs JC; Herzig RH; Klein JP; McGlave PB; Schiller G; Gale RP; Rowlings PA; Horowitz MM
Blood; 2000 Jan; 95(2):410-5. PubMed ID: 10627443
[TBL] [Abstract][Full Text] [Related]
9. Alpha-interferon in chronic myelogenous leukaemia.
Kumar L; Gulati SC
Lancet; 1995 Oct; 346(8981):984-6. PubMed ID: 7475589
[No Abstract] [Full Text] [Related]
10. Treatment of chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation: the case for giving interferon.
Steegmann JL; Casado F; Granados E; Fernández Rañada JM
Blood; 1998 Apr; 91(7):2617-8. PubMed ID: 9516164
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
Enright H; Davies S; McGlave P
Clin Transpl; 1994; ():283-93. PubMed ID: 7547549
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia. Introduction.
Frame D
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S2-3. PubMed ID: 18056928
[No Abstract] [Full Text] [Related]
13. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
[TBL] [Abstract][Full Text] [Related]
14. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
Hehlmann R; Hochhaus A; Kolb HJ; Hasford J; Gratwohl A; Heimpel H; Siegert W; Finke J; Ehninger G; Holler E; Berger U; Pfirrmann M; Muth A; Zander A; Fauser AA; Heyll A; Nerl C; Hossfeld DK; Löffler H; Pralle H; Queisser W; Tobler A
Blood; 1999 Dec; 94(11):3668-77. PubMed ID: 10572078
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-alpha therapy in chronic myelogenous leukemia].
Ohnishi K
Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
[No Abstract] [Full Text] [Related]
17. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
18. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
Bren A; Kandus A; Ferluga D
Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukemia.
Sawyers CL
N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
[No Abstract] [Full Text] [Related]
20. NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
Berman E; Clift RA; Copelan EA; Emanuel PD; Erba HP; Glenn MJ; Greenberg PL; Jones RJ; O'Brien S; Saba HI; Schilder R; Snyder DS; Soiffer RJ; Tallman MS; Wetzler M; Ravandi-Kashani F; Kantarjian H; Talpaz M;
Oncology (Williston Park); 2000 Nov; 14(11A):229-40. PubMed ID: 11195415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
